Ron Renaud Appointed to Lead Cerevel Therapeutics as President and Chief Executive Officer

Cambridge, MA, May 3, 2023 (Globe Newswire) -- Cerevel Therapeutics has appointed Ron Renaud as its new CEO, succeeding Tony Coles, who will remain chairperson of the board. Renaud brings over 25 years of experience in biotech leadership, with prior CEO roles at companies such as Translate Bio and Idenix Pharmaceuticals.

Read full article here.